December 20, 2024
TOPLINE: Among children with traumatic injury, those of Black ethnicity are more likely than those of White ethnicity to be suspected of experiencing child abuse. Young […]
December 20, 2024
TOPLINE: A retrospective analysis finds no adverse events (AEs) in children receiving a live attenuated vaccine against measles, mumps, rubella, and varicella (MMRV) while on dupilumab […]
December 20, 2024
TOPLINE: Pilot study finds a non-significant 8 mmol/mol reduction in A1c following the use of intermittent scanning continuous glucose monitoring (isCGM) among adults with type 2 […]
December 20, 2024
TOPLINE: Among the digital health interventions (DHIs) available for people with hypertension, applications seem to work best, although the effect size is modest. METHODOLOGY: A systematic […]
December 20, 2024
TOPLINE: Achieving serum urate to below 6 mg/dL with urate-lowering therapy (ULT) in patients with gout and chronic kidney disease (CKD) stage III is not linked […]
December 20, 2024
TOPLINE: Patients with anorexia nervosa are at significantly increased risk for cardiovascular conditions such as congestive heart failure and cardiac arrest compared with people without an […]
December 20, 2024
TOPLINE: SAN DIEGO — Despite its significantly higher acquisition costs, lisocabtagene maraleucel (liso-cel, Breyanzi) demonstrated better survival and quality of life as well as fewer time […]
December 19, 2024
TOPLINE: Perfluorohexanoic acid (PFHxA) is found in fluoroelastomer watch bands at concentrations of up to 16,662 ng/g, highlighting the need for further research on dermal absorption […]
December 19, 2024
TOPLINE: Survivors of blood or marrow transplant (BMT) face a significant risk of developing cutaneous malignant neoplasms, including basal cell carcinoma (BCC), squamous cell carcinoma (SCC), […]